2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.
Lara S. Sullivan
Protein Metrics
2 followers
Obsidian Therapeutics
1 follower
Ensoma
1 follower
Tenax Therapeutics
1 follower
Metagenomi
3 followers
Thermo Fisher Scientific
182 followers
Genentech
163 followers
Gilead Sciences
138 followers
Regeneron
105 followers
Vertex Pharmaceuticals
66 followers
Roivant Sciences
56 followers
Explore companies